Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases
ConclusionThe CRISPR/Cas9 gene editing tool is a powerful arsenal in the field of gene therapy and molecular medicine; hence, more research should be called to focus on the ample potential this tool has to offer in the field of neurodegenerative diseases.
Source: Neurological Sciences - Category: Neurology Source Type: research
More News: Alzheimer's | Brain | Gene Therapy | Genetics | Muscular Dystrophy | Neurology | Reflex Sympathetic Dystrophy | Study